The SH2 domain of STAT3 has been found to be mutated in patients with large granular lymphocytic leukemia as well as other types of leukemias, thus indicating that anomalous STAT3 signaling may be underlying the pathogenesis of these diseases [45,46]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.